Rchr
J-GLOBAL ID：202201020094659517
Update date: Jan. 30, 2024
Hirasawa Takeshi
ヒラサワ タケシ | Hirasawa Takeshi
Affiliation and department：
Research theme for competitive and other funds (7)：
- 2020 - 2024 既成概念を打破する血清網羅的糖ペプチド解析による卵巣癌早期診断の社会実装
- 2018 - 2021 Development of hemodiagnosis for early detection of ovarian cancer with AI using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)
- 2018 - 2021 The vaginal microbiome in pathogenesis of endometriosis and endometriosis-related ovarian cancer
- 2017 - 2021 Development of hemodiagnosis for early detection of ovarian cancer using glycopeptide peaks obtained from CSGSA (Comprehensive Serum Glycopeptide Spectra Analysis)
- 2011 - 2013 Drug discovery and a new carcinogenic process in the clear cell adenocarcinoma of uterine body
- 2011 - 2013 Expression and Bio-function of Sugar chains in uterine endometrial adenocarcinoma, cervical carcinoma and uterine endometrium
- 2008 - 2010 Bio-function of glycolipids in uterine endometrial adencarcinoma and cervical carcinoma, and uterine endometrium
Show all
Papers (473)：
-
Hiroko Machida, Koji Matsuo, Masayuki Tanaka, Kanae Kitatani, Akinori Takase, Keiko Yokoyama, Hiroshi Kajiwara, Miwa Yasaka, Masae Ikeda, Hiroshi Yoshida, et al. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology. 2023. 171. 59-66
-
Masae Ikeda, Miwa Yasaka, Tetsuji Iida, Masako Shida, Hiroshi Yoshida, Takeshi Hirasawa, Mikio Mikami. Pyogenic Spondylitis in Multidisciplinary Therapies of Gynecologic Malignancies: Three Cases Reports. The Tokai journal of experimental and clinical medicine. 2021. 46. 2. 118-122
-
磯崎 太一, 沼崎 令子, 新井 努, ルイズ横田 奈朋, 吉田 浩, 杉浦 賢, 大原 樹, 高田 恭臣, 木挽 貢慈, 佐々木 康, et al. 令和元年度神奈川県産科婦人科医会 婦人科悪性腫瘍登録集計報告. 神奈川産科婦人科学会誌. 2021. 57. 2. 190-190
-
Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, Shinichi Komiyama, et al. Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer. Journal of gynecologic oncology. 2021. 32. 2. e16
-
Tetsuji Iida, Toshinari Muramatsu, Hiroshi Kajiwara, Nobuaki Kato, Hitoshi Itoh, Tomoaki Narayama, Hiroko Machida, Masae Ikeda, Masako Shida, Takeshi Hirasawa, et al. Small Cell Neuroendocrine Carcinoma of the Endometrium with Difficulty Identifying the Original Site in the Uterus. The Tokai journal of experimental and clinical medicine. 2020. 45. 4. 156-161
ｍore...
MISC (29)：
-
中村 俊昭, 田畑 務, 柳田 聡, 近藤 英司, 濱西 潤三, 原野 謙一, 長谷川 幸清, 平澤 猛, 堀 謙輔, 小宮山 慎一, et al. 前治療歴を有する高悪性度漿液性卵巣癌患者を対象としたニラパリブの国内第II相臨床試験の最終結果(The Final Results of a Japanese Phase 2 Study of Niraparib in Heavily Pretreated, HRd High-grade Serous Ovarian Cancer Patients). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 193-193
-
矢島 優希, 矢坂 美和, 百瀬 浩晃, 飯田 哲士, 池田 仁惠, 吉田 浩, 平澤 猛, 三上 幹男, 石本 人士. 子宮腺筋症から発生した子宮癌肉腫の一例. 関東連合産科婦人科学会誌. 2021. 58. 3. 395-395
-
樽見 知奈美, 矢坂 美和, 義澤 航平, 岡宮 稜子, 百瀬 浩晃, 飯田 哲士, 池田 仁恵, 信田 政子, 吉田 浩, 平澤 猛, et al. 卵巣癌との鑑別が困難であった後腹膜軟部肉腫の1例. 神奈川産科婦人科学会誌. 2021. 58. 1. 115-115
-
百瀬 浩晃, 吉田 浩, 矢坂 美和, 飯田 哲士, 池田 仁惠, 平澤 猛, 三上 幹男. 肥満を合併した子宮体癌患者に対する傍大動脈リンパ節摘出を伴った腹腔鏡下手術(Laparoscopic surgery including para-aortic lymphadenectomy for endometrial cancer with obesity). 日本産科婦人科内視鏡学会雑誌. 2021. 37. Suppl.I. 330-330
-
樽見 知奈美, 矢坂 美和, 義澤 航平, 岡宮 稜子, 百瀬 浩晃, 飯田 哲士, 池田 仁恵, 信田 政子, 吉田 浩, 平澤 猛, et al. 卵巣癌との鑑別が困難であった後腹膜軟部肉腫の一例. 神奈川医学会雑誌. 2021. 48. 2. 47-47
ｍore...
Return to Previous Page
